Atlas Trials

Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia

Clinical trial NCT04527224 · UNKNOWN

Trial details

NCT number
NCT04527224
Sponsor
Nature Cell Co. Ltd.
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Covid19 Pneumonia
Start date
2022-10-24
Primary completion
2023-11-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.